LifeMD Ebit Per Revenue vs Capex To Revenue Analysis

LFMD Stock

USD 5.97 0.07 1.19%

LifeMD financial indicator trend analysis is infinitely more than just investigating LifeMD Inc recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether LifeMD Inc is a good investment. Please check the relationship between LifeMD Ebit Per Revenue and its Capex To Revenue accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LifeMD Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

Ebit Per Revenue vs Capex To Revenue

Ebit Per Revenue vs Capex To Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of LifeMD Inc Ebit Per Revenue account and Capex To Revenue. At this time, the significance of the direction appears to have very week relationship.

The correlation between LifeMD's Ebit Per Revenue and Capex To Revenue is 0.29. Overlapping area represents the amount of variation of Ebit Per Revenue that can explain the historical movement of Capex To Revenue in the same time period over historical financial statements of LifeMD Inc, assuming nothing else is changed. The correlation between historical values of LifeMD's Ebit Per Revenue and Capex To Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ebit Per Revenue of LifeMD Inc are associated (or correlated) with its Capex To Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capex To Revenue has no effect on the direction of Ebit Per Revenue i.e., LifeMD's Ebit Per Revenue and Capex To Revenue go up and down completely randomly.

Correlation Coefficient

0.29

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Ebit Per Revenue

Capex To Revenue

The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.

Most indicators from LifeMD's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into LifeMD Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LifeMD Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

At present, LifeMD's Discontinued Operations is projected to increase significantly based on the last few years of reporting. The current year's Tax Provision is expected to grow to about 449.4 K, whereas Sales General And Administrative To Revenue is forecasted to decline to 0.32.

	2021	2022	2023	2024 (projected)
Interest Expense	3.0M	1.3M	2.6M	2.7M
Depreciation And Amortization	868.8K	3.8M	6.6M	6.9M

Interest Expense Depreciation And Amortization

LifeMD fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Common Stock	Non Currrent Assets Other	Other Current Assets	Current Deferred Revenue
Total Assets		0.86	0.96	0.94	0.48	0.76	-0.76	-0.94	0.88	0.96	0.88	0.96	0.89	0.03	0.95	0.84	0.81	0.97	0.95	0.76	0.99	0.49	0.07	-0.22	0.85	0.89
Short Long Term Debt Total	0.86		0.8	0.84	0.07	0.4	-0.37	-0.82	0.72	0.74	0.89	0.74	0.97	0.13	0.83	1.0	0.72	0.84	0.93	0.4	0.8	0.33	0.18	0.03	0.8	0.95
Other Current Liab	0.96	0.8		0.97	0.4	0.84	-0.7	-0.96	0.88	0.88	0.92	0.88	0.86	0.12	0.98	0.76	0.9	0.97	0.95	0.84	0.92	0.68	0.16	-0.43	0.8	0.88
Total Current Liabilities	0.94	0.84	0.97		0.24	0.79	-0.59	-1.0	0.95	0.81	0.96	0.81	0.92	0.0	0.99	0.79	0.94	1.0	0.98	0.79	0.88	0.72	0.04	-0.45	0.87	0.94
Total Stockholder Equity	0.48	0.07	0.4	0.24		0.54	-0.92	-0.25	0.29	0.7	0.04	0.7	0.04	-0.08	0.3	0.08	0.07	0.32	0.2	0.54	0.61	-0.07	-0.07	0.02	0.25	0.03
Property Plant And Equipment Net	0.76	0.4	0.84	0.79	0.54		-0.74	-0.81	0.74	0.72	0.68	0.72	0.53	-0.17	0.81	0.34	0.75	0.81	0.68	1.0	0.74	0.77	-0.15	-0.71	0.53	0.58
Net Debt	-0.76	-0.37	-0.7	-0.59	-0.92	-0.74		0.6	-0.63	-0.9	-0.39	-0.9	-0.39	0.1	-0.62	-0.37	-0.41	-0.65	-0.54	-0.74	-0.85	-0.21	0.08	0.13	-0.57	-0.38
Retained Earnings	-0.94	-0.82	-0.96	-1.0	-0.25	-0.81	0.6		-0.94	-0.81	-0.96	-0.81	-0.92	0.02	-0.99	-0.77	-0.94	-1.0	-0.97	-0.81	-0.88	-0.74	-0.02	0.47	-0.86	-0.93
Accounts Payable	0.88	0.72	0.88	0.95	0.29	0.74	-0.63	-0.94		0.79	0.83	0.79	0.82	-0.05	0.92	0.67	0.89	0.93	0.9	0.74	0.84	0.69	-0.02	-0.41	0.95	0.82
Cash	0.96	0.74	0.88	0.81	0.7	0.72	-0.9	-0.81	0.79		0.7	1.0	0.73	-0.01	0.84	0.73	0.63	0.86	0.83	0.72	0.99	0.3	0.03	-0.08	0.79	0.72
Non Current Assets Total	0.88	0.89	0.92	0.96	0.04	0.68	-0.39	-0.96	0.83	0.7		0.7	0.96	0.07	0.95	0.85	0.93	0.95	0.97	0.68	0.78	0.71	0.11	-0.42	0.77	0.98
Cash And Short Term Investments	0.96	0.74	0.88	0.81	0.7	0.72	-0.9	-0.81	0.79	1.0	0.7		0.73	-0.01	0.84	0.73	0.63	0.86	0.83	0.72	0.99	0.3	0.03	-0.08	0.79	0.72
Net Receivables	0.89	0.97	0.86	0.92	0.04	0.53	-0.39	-0.92	0.82	0.73	0.96	0.73		0.08	0.91	0.94	0.84	0.92	0.98	0.53	0.81	0.52	0.12	-0.19	0.84	0.99
Common Stock Total Equity	0.03	0.13	0.12	0.0	-0.08	-0.17	0.1	0.02	-0.05	-0.01	0.07	-0.01	0.08		0.05	0.15	0.18	-0.01	0.05	-0.17	0.02	-0.01	1.0	0.1	-0.01	0.06
Common Stock Shares Outstanding	0.95	0.83	0.98	0.99	0.3	0.81	-0.62	-0.99	0.92	0.84	0.95	0.84	0.91	0.05		0.78	0.94	0.99	0.97	0.81	0.9	0.72	0.09	-0.45	0.84	0.93
Non Current Liabilities Total	0.84	1.0	0.76	0.79	0.08	0.34	-0.37	-0.77	0.67	0.73	0.85	0.73	0.94	0.15	0.78		0.66	0.79	0.9	0.34	0.79	0.24	0.2	0.12	0.77	0.92
Inventory	0.81	0.72	0.9	0.94	0.07	0.75	-0.41	-0.94	0.89	0.63	0.93	0.63	0.84	0.18	0.94	0.66		0.92	0.89	0.75	0.72	0.85	0.2	-0.61	0.78	0.87
Other Stockholder Equity	0.97	0.84	0.97	1.0	0.32	0.81	-0.65	-1.0	0.93	0.86	0.95	0.86	0.92	-0.01	0.99	0.79	0.92		0.98	0.81	0.92	0.68	0.02	-0.42	0.87	0.93
Total Liab	0.95	0.93	0.95	0.98	0.2	0.68	-0.54	-0.97	0.9	0.83	0.97	0.83	0.98	0.05	0.97	0.9	0.89	0.98		0.68	0.89	0.6	0.09	-0.28	0.88	0.98
Property Plant And Equipment Gross	0.76	0.4	0.84	0.79	0.54	1.0	-0.74	-0.81	0.74	0.72	0.68	0.72	0.53	-0.17	0.81	0.34	0.75	0.81	0.68		0.74	0.77	-0.15	-0.71	0.53	0.58
Total Current Assets	0.99	0.8	0.92	0.88	0.61	0.74	-0.85	-0.88	0.84	0.99	0.78	0.99	0.81	0.02	0.9	0.79	0.72	0.92	0.89	0.74		0.39	0.06	-0.14	0.84	0.8
Short Term Debt	0.49	0.33	0.68	0.72	-0.07	0.77	-0.21	-0.74	0.69	0.3	0.71	0.3	0.52	-0.01	0.72	0.24	0.85	0.68	0.6	0.77	0.39		0.0	-0.9	0.46	0.58
Common Stock	0.07	0.18	0.16	0.04	-0.07	-0.15	0.08	-0.02	-0.02	0.03	0.11	0.03	0.12	1.0	0.09	0.2	0.2	0.02	0.09	-0.15	0.06	0.0		0.1	0.02	0.11
Non Currrent Assets Other	-0.22	0.03	-0.43	-0.45	0.02	-0.71	0.13	0.47	-0.41	-0.08	-0.42	-0.08	-0.19	0.1	-0.45	0.12	-0.61	-0.42	-0.28	-0.71	-0.14	-0.9	0.1		-0.12	-0.26
Other Current Assets	0.85	0.8	0.8	0.87	0.25	0.53	-0.57	-0.86	0.95	0.79	0.77	0.79	0.84	-0.01	0.84	0.77	0.78	0.87	0.88	0.53	0.84	0.46	0.02	-0.12		0.82
Current Deferred Revenue	0.89	0.95	0.88	0.94	0.03	0.58	-0.38	-0.93	0.82	0.72	0.98	0.72	0.99	0.06	0.93	0.92	0.87	0.93	0.98	0.58	0.8	0.58	0.11	-0.26	0.82

Click cells to compare fundamentals

LifeMD Account Relationship Matchups

LifeMD fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	3.4M	13.1M	49.9M	25.7M	58.5M	61.4M
Short Long Term Debt Total	844.7K	1.1M	1.8M	4.1M	18.9M	19.9M
Other Current Liab	3.1M	1.6M	10.0M	8.9M	10.8M	11.4M
Total Current Liabilities	4.0M	13.5M	22.8M	31.4M	34.8M	36.5M
Total Stockholder Equity	(988.2K)	1.4M	26.9M	(6.8M)	3.5M	2.1M
Net Debt	(261.9K)	(8.1M)	(39.5M)	168.5K	(14.2M)	(13.5M)
Retained Earnings	(16.6M)	(80.2M)	(141.9M)	(190.6M)	(214.3M)	(203.6M)
Accounts Payable	3.1M	10.4M	9.1M	10.1M	11.1M	11.6M
Cash	1.1M	9.2M	41.3M	4.0M	33.1M	34.8M
Non Current Assets Total	699.1K	990.3K	5.0M	14.4M	15.9M	16.7M
Cash And Short Term Investments	1.1M	9.2M	41.3M	4.0M	33.1M	34.8M
Net Receivables	97.4K	997.8K	980.1K	2.8M	5.3M	5.5M
Common Stock Total Equity	534.0K	234.3K	307.0K	315.5K	362.9K	377.1K
Common Stock Shares Outstanding	9.9M	14.3M	27.0M	31.0M	33.9M	35.6M
Liabilities And Stockholders Equity	3.4M	13.1M	49.9M	25.7M	58.5M	61.4M
Non Current Liabilities Total	600.0K	385.3K	1.3M	1.6M	18.1M	19.0M
Inventory	950.1K	1.3M	1.6M	3.7M	2.8M	2.9M
Other Stockholder Equity	15.1M	77.6M	164.4M	178.9M	217.4M	228.3M
Total Liab	4.6M	13.9M	24.1M	33.0M	52.9M	55.6M
Total Current Assets	2.7M	12.1M	44.9M	11.3M	42.6M	44.7M
Short Term Debt	814.7K	872.1K	1.3M	4.3M	1.5M	903.8K
Common Stock	534.0K	234.3K	307.0K	315.5K	383.6K	380.6K
Other Current Assets	443.0K	1.8M	996.7K	814.3K	1.9M	2.0M
Current Deferred Revenue	109.6K	916.9K	1.5M	5.5M	8.8M	9.3M
Net Tangible Assets	(1.7M)	(3.0M)	19.7M	(19.5M)	(17.6M)	(16.7M)
Net Invested Capital	(173.5K)	(1.5M)	22.8M	(8.6M)	21.8M	22.8M
Short Long Term Debt	814.7K	779.1K	63.4K	2.8M	327.6K	311.2K
Net Working Capital	(1.2M)	(1.4M)	22.1M	(20.1M)	7.8M	8.2M
Capital Stock	534.0K	3.9M	4.4M	4.9M	383.7K	364.5K
Intangible Assets	675.5K	715.8K	3.0M	12.7M	14.8M	15.5M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

When determining whether LifeMD Inc is a strong investment it is important to analyze LifeMD's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact LifeMD's future performance. For an informed investment choice regarding LifeMD Stock, refer to the following important reports:

How To Invest In LifeMD

Details

Is LifeMD Stock a good investment?

Details

What is LifeMD's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LifeMD Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of LifeMD. If investors know LifeMD will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about LifeMD listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.64)

Revenue Per Share

4.847

Quarterly Revenue Growth

0.383

Return On Assets

(0.21)

Return On Equity

(7.82)

The market value of LifeMD Inc is measured differently than its book value, which is the value of LifeMD that is recorded on the company's balance sheet. Investors also form their own opinion of LifeMD's value that differs from its market value or its book value, called intrinsic value, which is LifeMD's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because LifeMD's market value can be influenced by many factors that don't directly affect LifeMD's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between LifeMD's value and its price as these two are different measures arrived at by different means. Investors typically determine if LifeMD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, LifeMD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

LifeMD Ebit Per Revenue vs Capex To Revenue Analysis

Ebit Per Revenue vs Capex To Revenue

Ebit Per Revenue vs Capex To Revenue Correlation Analysis

Correlation Coefficient

Ebit Per Revenue

Capex To Revenue

LifeMD fundamental ratios Correlations

LifeMD Account Relationship Matchups

High Positive Relationship

High Negative Relationship

LifeMD fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Liabilities Total	+ 1.0	Short Long Term Debt Total
Other Stockholder Equity	+ 1.0	Total Current Liabilities
Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Cash And Short Term Investments	+ 1.0	Cash
Common Stock	+ 1.0	Common Stock Total Equity
Total Current Assets	+ 0.99	Total Assets

Other Stockholder Equity	- 1.0	Retained Earnings
Retained Earnings	- 1.0	Total Current Liabilities
Common Stock Shares Outstanding	- 0.99	Retained Earnings
Total Liab	- 0.97	Retained Earnings
Non Current Assets Total	- 0.96	Retained Earnings
Retained Earnings	- 0.96	Other Current Liab